Tandem Launches t:slim X2 Pump with Abbott FreeStyle Libre 3 Plus
Tandem Diabetes Care announced the rollout of its latest automated insulin delivery system integration, combining the t:slim X2 insulin pump with Control-IQ+ technology and Abbott's FreeStyle Libre 3 Plus CGM sensor in the U.S.
The new pairing follows the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in January 2024, marking the latest collaboration between the two diabetes technology developers.
Tandem initiated an early access program for integration in the U.S. after the companies agreed to integrate systems in June, with plans to scale availability in the second half of 2025.
Tandem teased the launch on social media earlier this month.
The rollout brings together Tandem's flagship automated insulin delivery system and Abbott's latest continuous glucose monitor sensor.
Author's summary: Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus integration.